https://www.selleckchem.com/ALK.html
ACTA2-AS1 inhibitor is expected to play a role in targeted therapy of OC. Glioblastoma (GBM) is an aggressive brain tumor and the mechanisms of progression are very complex. Accelerated aging is a driving factor of GBM. However, there has not been thorough research about the mechanisms of GBM progression based on aging acceleration. The aging predictor was modeled based on normal brain samples. Then an aging acceleration background network was constructed to explore GBM mechanisms. The accelerated aging-related mechanisms provided an innovative way